When Mark Carney was asked on the campaign trail about whether federal approval for injection sites would continue under his government, he avoided the contentious topic by saying the effectiveness of those sites was under review.
Even in his evasion, our new prime minister was undermining the position staked out by his predecessor, Justin Trudeau. When asked about such controversial initiatives as injection sites and the distribution of so-called “safer supply” opioids to those with severe addictions, the latter was fond of insisting his government was simply “following the science.”
